Search for: "In re JOHNSON" Results 781 - 800 of 5,579
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
22 Feb 2011, 6:13 am
Professional Links:  http://www.linkedin.com/pub/tina-m-johnson/10/181/3b6; http://www.gpmlaw.com/professionals/tina-m-johnson.aspx ________________________ Many thanks to Tina for taking the time to share her profile - and her taco dip recipe. [read post]
30 Aug 2009, 2:29 am
Johnson testified, "I was frustrated that the protocol had not been followed. [read post]
10 Sep 2023, 4:00 am by SHG
They’re imperfect as a predictor, but pretty darn good. [read post]
19 Apr 2018, 3:30 am by Eric B. Meyer
If you’re interested in learning more about the training module, you may be in luck. [read post]
19 Apr 2018, 3:30 am by Eric B. Meyer
If you’re interested in learning more about the training module, you may be in luck. [read post]
1 Dec 2016, 7:32 am by Robert Kraft
Freedom of speech has been an important issue throughout history, particularly in modern times when we’re surrounded by print, television, and digital media. [read post]
16 Jul 2008, 3:13 am
They're also getting rid of minimum billable hour requirements and high-priced associates. [read post]
4 Jun 2024, 3:54 pm
Johnson knew no permits had been pulled for the project. [read post]
12 Aug 2014, 4:37 am by Jon Hyman
While Member Johnson is 100% correct, his view is the minority view (at least for the next 30 months). [read post]
5 Jul 2019, 12:39 pm by Mark Theodore and Joshua Fox
  Yet under that framework, the employer would be susceptible to a successful 8(a)(5) charge for refusal to bargain if – at the time the employer actually withdraws – there is evidence that the union re-acquired majority support. [read post]
4 Nov 2013, 3:04 am by Ben Vernia
On November 4, the Department of Justice announced that Johnson & Johnson and its subsidiaries, Janssen Pharmaceuticals, Inc., and Scios, Inc., had agreed to pay $2.2 billion to resolve claims originally brought by whistleblowers that the company promoted its drugs Risperdal, Invega, and Natrecor for unapproved (off-label) uses. [read post]
Johnson & Johnson, 593 F.3d 280 (3d Cir. 2010), decided by the Court of Appeals for the Third Circuit in February, the court affirmed the district court’s holding that the pharmaceutical sales representative (Patty Smith) was exempt from overtime pay under the administrative employee exception. [read post]
17 Aug 2011, 8:02 am by Steve Hall
That's the title of Carrie Johnson's NPR report for All Things Considered. [read post]